Endocrine disrupting chemicals and their effects on the reproductive health in men.


Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
01 11 2023
Historique:
received: 23 04 2023
revised: 26 07 2023
accepted: 02 08 2023
medline: 10 10 2023
pubmed: 7 8 2023
entrez: 6 8 2023
Statut: ppublish

Résumé

Endocrine Disrupting Chemicals (EDCs) are harmful compounds that enter the environment naturally or through anthropogenic activities and disrupt normal endocrine functions in humans, adversely affecting reproductive health. Among the most significant sources of EDC contaminants are the pharmaceutical, cosmetic, and packaging industries. EDCs have been identified to have a deteriorating effect on male reproductive system, as evidenced by the increasing number of male infertility cases. A large number of case studies have been published in which men exposed to EDCs experienced testicular cancer, undescended testicles, a decrease in serum testosterone levels, and poor semen quality. Furthermore, epidemiological evidence suggested a link between prenatal EDC exposure and cryptorchidism or undescended testicles, hypospadias, and decreased anogenital distance in infants. The majority of these findings, however, are incongruent due to the lack of long-term follow-up studies that would demonstrate EDCs to be associated with male reproductive disorders. This review aims to provide an overview on recent scientific progress on the association of EDCs to male reproductive health with special emphasis on its toxicity and possible mechanism of EDCs that disrupt male reproductive system.

Identifiants

pubmed: 37544467
pii: S0013-9351(23)01629-8
doi: 10.1016/j.envres.2023.116825
pii:
doi:

Substances chimiques

Endocrine Disruptors 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116825

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Aswin Thacharodi (A)

Dr. Thacharodi's Laboratories, Department of Research and Development, Puducherry, 605005, India.

Saqib Hassan (S)

Department of Biotechnology, School of Bio and Chemical Engineering, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, 600119, India; American Society for Microbiology, Washington, 20036, USA.

Gururaj Acharya (G)

Department of Civil Engineering, NMAM Institute of Technology, NITTE (Deemed to be university), Karnataka, 574110, India.

Avadh Vithlani (A)

Department of Pulmonary Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.

Quynh Hoang Le (Q)

School of Medicine and Pharmacy, Duy Tan University, Da Nang, Viet Nam; Institute of Research and Development, Duy Tan University, Da Nang, Viet Nam.

Arivalagan Pugazhendhi (A)

School of Medicine and Pharmacy, Duy Tan University, Da Nang, Viet Nam; Institute of Research and Development, Duy Tan University, Da Nang, Viet Nam. Electronic address: arivalaganpugazhendhi@duytan.edu.vn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH